Nucleic Acid Biochemistry Practice Questions

Q: What is the end product of purine metabolism in most mammals?

Allantoin. ***Allantoin*** - **Allantoin** is the primary end product of **purine metabolism** in **most mammals** (except humans and higher primates), formed by the oxidation of uric acid by the enzyme **uricase**. - This conversion makes purine waste products more **water-soluble** and easier to excrete via the kidneys. - **Important clinical note:** Humans lack functional uricase, so **uric acid** is the end product in humans; this distinction is why hyperuricemia and gout occur in humans but not in most other mammals. *Glycogen* - **Glycogen** is a complex carbohydrate and serves as a primary **energy storage molecule** in animals, derived from glucose metabolism, not purine catabolism. - Its metabolism is regulated by hormones like **insulin** and **glucagon**, involved in maintaining blood glucose levels. *Pyrimidine* - **Pyrimidine** is a type of nitrogenous base, structurally distinct from purines, and is a component of DNA and RNA, not an end product of purine catabolism. - **Pyrimidine metabolism** involves the synthesis and breakdown of bases like cytosine, thymine, and uracil, which follows a separate biochemical pathway. *Histidine* - **Histidine** is an **essential amino acid**, a building block of proteins, and is involved in various metabolic processes, including histamine synthesis. - It plays no role as an end product of purine degradation; rather, its own metabolism leads to products like **urocanic acid**.

Q: Which of the following molecular interactions are found in the structure of DNA?

All of the options. ***All of the options*** - All three types of molecular interactions listed are present in DNA structure, making this the correct answer. - **Hydrogen bonds** hold together the two strands of the DNA double helix, forming between complementary base pairs (A-T with 2 hydrogen bonds, G-C with 3 hydrogen bonds). - **Glycosidic bonds** (N-glycosidic bonds) link the nitrogenous bases to the C1' carbon of the deoxyribose sugar in each nucleotide. - **Covalent interactions** (phosphodiester bonds) form the strong, stable sugar-phosphate backbone by linking the 3' hydroxyl group of one sugar to the 5' phosphate group of the next. *Hydrogen bond* - This is a **true statement** - hydrogen bonds are essential structural components of DNA. - However, this option alone is **incomplete** as DNA structure also contains glycosidic bonds and covalent phosphodiester bonds. - If only hydrogen bonds were present, there would be no nucleotides or backbone structure. *Glycosidic bond* - This is a **true statement** - glycosidic bonds are present in every nucleotide of DNA. - However, this option alone is **incomplete** as DNA also requires hydrogen bonds for base pairing and phosphodiester bonds for the backbone. - Without other bonds, individual nucleotides could not form a functional double helix. *Covalent interactions* - This is a **true statement** - covalent phosphodiester bonds form the DNA backbone within each strand. - However, this option alone is **incomplete** as it doesn't account for glycosidic bonds (nucleotide formation) or hydrogen bonds (strand pairing). - While the strongest bonds in DNA, they alone cannot create the complete double helix structure.

Q: Which type of RNA is most commonly associated with pseudouridine?

transfer RNA (tRNA). ***Transfer RNA (tRNA)*** - **Pseudouridine (ψ)** is one of the most abundant modified nucleosides in RNA, and **tRNA contains the highest proportion** of pseudouridine modifications among all RNA types. - **tRNA molecules can contain up to 10-15% modified bases**, with pseudouridine being particularly abundant in the **TψC arm** (thymine-pseudouridine-cytosine loop). - These modifications are critical for **tRNA stability, proper folding, and accurate codon-anticodon recognition** during translation. - Pseudouridine enhances base stacking and stabilizes RNA structure through additional hydrogen bonding capability. *Ribosomal RNA (rRNA)* - While rRNA does contain pseudouridine modifications, they are present in **lower proportions compared to tRNA**. - rRNA pseudouridine modifications do play important roles in **ribosomal assembly and function**, but tRNA remains the RNA type most commonly associated with this modification. *Messenger RNA (mRNA)* - **mRNA is generally much less modified** than tRNA or rRNA. - Pseudouridine modifications in mRNA are relatively rare in prokaryotes and were only recently discovered to be more common in eukaryotic mRNA. - When present, they may affect **mRNA stability and translation efficiency**. *DNA* - **DNA does not contain pseudouridine** as this is an RNA-specific modification. - Pseudouridine is formed by **post-transcriptional isomerization** of uridine residues in RNA.

Q: What does salvage purine synthesis refer to?

Synthesis of purine nucleotides from purine bases. ***Synthesis of purine nucleotides from purine bases*** - **Salvage pathways** recycle pre-existing purine or pyrimidine bases (from nucleic acid degradation) by re-attaching them to a **ribose phosphate** to form a new nucleotide. - This process is energy-efficient as it bypasses several steps of the de novo synthesis pathway, utilizing enzymes like **adenine phosphoribosyltransferase (APRT)** and **hypoxanthine-guanine phosphoribosyltransferase (HGPRT)**. *Synthesis of purine nucleotides from ribose-5-phosphate.* - While **ribose-5-phosphate** is a precursor, the complete synthesis from this molecule is part of the **de novo pathway**, which starts with PRPP (phosphoribosyl pyrophosphate) formation from ribose-5-phosphate. - This option does not specify the direct reuse of a pre-formed purine base, which is the hallmark of salvage. *Synthesis of purine nucleotides from simple precursors (de novo synthesis).* - **De novo synthesis** is the creation of nucleotides from scratch using simple metabolic precursors like amino acids (glycine, aspartate, glutamine), CO2, and THF derivatives. - This contrasts with salvage pathways, which recycle existing bases. *Synthesis of purine nucleotides from degraded RNA.* - Degraded RNA breaks down into **nucleotides**, which can then be further broken down into **purine bases** and ribose phosphates. - The direct synthesis of purine nucleotides from *degraded RNA* involves recovering the individual bases or nucleosides, then converting them to nucleotides via salvage, not directly using the entire degraded RNA.

Q: What is the end product of purine metabolism in humans?

Uric acid. ***Uric acid*** - **Uric acid** is the final breakdown product of **purine metabolism** in humans. - It is formed from the degradation of **adenosine** and **guanosine**, with xanthine oxidase playing a key role in its synthesis. *Allantoin* - **Allantoin** is the end product of **purine metabolism** in most mammals other than primates, as they possess the enzyme **uricase** to further break down uric acid. - Humans lack **uricase**, hence allantoin is not the end product in humans. *Carbon Dioxide* - **Carbon dioxide** is a major end product of **carbohydrate** and **fat metabolism** through cellular respiration. - It is not directly associated with the degradation pathway of purines. *None of the options* - This option is incorrect because **uric acid** is indeed the definitive end product of purine metabolism in humans.

Q: Rate limiting step in pyrimidine synthesis?

Carbamoyl phosphate synthase-II. ***Carbamoyl phosphate synthetase II (CPS-II)*** - **CPS-II** is the **committed and rate-limiting enzyme** in **de novo pyrimidine synthesis** in **mammals (including humans)** - It catalyzes the formation of **carbamoyl phosphate** from glutamine, CO₂, and 2 ATP in the **cytoplasm** - This is the **first committed step** and the main **regulatory checkpoint**, inhibited by UTP (feedback inhibition) and activated by PRPP and ATP - CPS-II is part of the **CAD complex** (carbamoyl phosphate synthetase, aspartate transcarbamoylase, dihydroorotase) in mammals *Aspartate transcarbamoylase (ATCase)* - ATCase catalyzes the **second step**: condensation of carbamoyl phosphate with aspartate to form carbamoyl aspartate - While ATCase is the **rate-limiting step in bacteria** (E. coli), in **mammals** it is part of the CAD complex and **not the primary regulatory step** - This option is incorrect for human/mammalian biochemistry tested in NEET PG *Dihydro-orotase* - The **third enzyme** in the pathway, converting carbamoyl aspartate to dihydroorotate - Part of the CAD complex in mammals but **not the rate-limiting step** *Dihydroorotate dehydrogenase* - Catalyzes the **fourth step**: oxidation of dihydroorotate to orotate - Located on the **outer surface of the inner mitochondrial membrane** (only mitochondrial enzyme in the pathway) - Important enzyme but **not rate-limiting**

Q: Which of the following organs does not primarily utilize the salvage pathway of purine nucleotide synthesis?

Liver. ***Liver*** - The **liver** is capable of both *de novo* synthesis and the salvage pathway of purine nucleotides, but it primarily utilizes the **de novo pathway** due to its high metabolic capacity and central role in biosynthesis for the entire body. - While salvage pathways exist, the liver's robust *de novo* synthesis allows it to readily produce purines from simple precursors, making it less reliant on salvaging pre-formed bases. *Brain* - The **brain** relies heavily on the **salvage pathway** for purine nucleotide synthesis because it has a limited capacity for *de novo* purine synthesis. - This dependency makes the brain particularly vulnerable to deficiencies in salvage enzymes, such as in **Lesch-Nyhan syndrome** where HGPRT deficiency leads to severe neurological dysfunction. *RBC* - **Red blood cells (RBCs)** are anucleated and lack the machinery for *de novo* purine synthesis, making them entirely dependent on the **salvage pathway** to maintain their purine nucleotide pool. - They salvage pre-formed purine bases and nucleosides from the plasma to synthesize necessary adenine and guanine nucleotides. *Leukocytes* - **Leukocytes**, particularly lymphocytes, have a high turn-over rate and metabolic activity, and they primarily rely on the **salvage pathway** for purine nucleotide synthesis. - The **immune system's rapid proliferation** and response demand efficient nucleotide synthesis, and the salvage pathway offers a quick and energy-efficient way to achieve this.

Q: What is the role of adenine phosphoribosyl transferase (APRT) in purine metabolism?

Salvage pathway of purine nucleotide synthesis. ***Salvage pathway of purine nucleotide synthesis*** - **Adenine phosphoribosyl transferase (APRT)** catalyzes the reaction of **adenine** with **5-phosphoribosyl-1-pyrophosphate (PRPP)** to form **adenosine monophosphate (AMP)**. - This reaction is a crucial step in the **purine salvage pathway**, which reclaims pre-formed purine bases and converts them back into nucleotides, conserving energy. *Breakdown of purines* - The breakdown of purines (catabolism) typically involves enzymes like **adenosine deaminase** and **xanthine oxidase**, leading to the formation of **uric acid**. - APRT is involved in synthesizing nucleotides, not their degradation. *Not involved in purine metabolism* - APRT is an enzyme specifically involved in the **anabolic processes** of purine metabolism, as it contributes to the formation of purine nucleotides. - Its role is well-established within the **salvage pathway**. *De novo synthesis of purines* - The **de novo synthesis pathway** builds purine nucleotides from simpler precursors like **amino acids**, **CO2**, and **THF derivatives**. - While both pathways produce purine nucleotides, APRT is exclusively part of the **salvage pathway**, which recycles existing purine bases.

Q: Which of the following is not a precursor in the synthesis of pyrimidines?

Thymidine. ***Thymidine*** - **Thymidine** is a *nucleoside* consisting of deoxyribose and thymine. It is a *product* and a component of DNA, not a precursor in the *de novo synthesis* of pyrimidine bases. - While it can be incorporated into DNA via the *salvage pathway*, it does not serve as an initial building block for the pyrimidine ring itself. *Glutamine* - **Glutamine** provides the **nitrogen atoms** crucial for the formation of the pyrimidine ring, specifically N3 in the pyrimidine base. - It is a key donor of *amino groups* in various anabolic pathways, including nucleotide synthesis. *Carbon dioxide (CO2)* - **Carbon dioxide (CO2)** contributes one of the carbon atoms (C2) to the pyrimidine ring. - It combines with **ammonia** (derived from glutamine) to form **carbamoyl phosphate**, an essential intermediate. *Aspartic acid* - **Aspartic acid** provides four atoms (N1, C4, C5, C6) of the pyrimidine ring. - Its carbon skeleton and amino group are directly incorporated into the pyrimidine structure during the *de novo synthesis* pathway.

Q: The anticodon region is an important part of which type of RNA?

t-RNA. **t-RNA** - The **anticodon region** is a critical component of **transfer RNA (tRNA)**, responsible for recognizing and binding to the complementary codon on mRNA during protein synthesis. - This interaction ensures that the correct **amino acid** is delivered to the growing polypeptide chain according to the genetic code. *r-RNA* - **Ribosomal RNA (rRNA)** is a structural and enzymatic component of **ribosomes**, which are the cellular machinery for protein synthesis. - While rRNA plays a crucial role in forming **peptide bonds** and facilitating translation, it does not possess an anticodon region. *m-RNA* - **Messenger RNA (mRNA)** carries the **genetic code** from DNA to the ribosomes in the form of codons, which specify the sequence of amino acids for protein synthesis. - mRNA molecules have codons, but they do not have an **anticodon region**; instead, they are read by the anticodons of tRNA. *hn-RNA* - **Heterogeneous nuclear RNA (hnRNA)** is a precursor to mRNA in eukaryotic cells, containing both exons and introns. - It undergoes extensive processing, including **splicing**, to become mature mRNA, but it does not have an **anticodon region**.

Question 1

What is the end product of purine metabolism in most mammals?

Accepted Answer

Allantoin

Answer

Glycogen

Answer

Pyrimidine

Answer

Histidine

Question 2

Which of the following molecular interactions are found in the structure of DNA?

Accepted Answer

All of the options

Answer

Hydrogen bond

Answer

Glycosidic bond

Answer

Covalent interactions

Question 3

Which type of RNA is most commonly associated with pseudouridine?

Accepted Answer

transfer RNA (tRNA)

Answer

messenger RNA (mRNA)

Answer

ribosomal RNA (rRNA)

Answer

DNA

Question 4

What does salvage purine synthesis refer to?

Accepted Answer

Synthesis of purine nucleotides from purine bases

Answer

Synthesis of purine nucleotides from ribose-5-phosphate

Answer

Synthesis of purine nucleotides from simple precursors (de novo synthesis)

Answer

Synthesis of purine nucleotides from degraded RNA

Question 5

What is the end product of purine metabolism in humans?

Accepted Answer

Uric acid

Answer

Carbon Dioxide

Answer

Allantoin

Answer

None of the options

Question 6

Rate limiting step in pyrimidine synthesis?

Accepted Answer

Carbamoyl phosphate synthase-II

Answer

Aspartate transcarbamoylase (ATCase)

Answer

Dihydroorotate dehydrogenase

Answer

Dihydro-orotase

Question 7

Which of the following organs does not primarily utilize the salvage pathway of purine nucleotide synthesis?

Accepted Answer

Liver

Answer

RBC

Answer

Leukocytes

Answer

Brain

Question 8

What is the role of adenine phosphoribosyl transferase (APRT) in purine metabolism?

Accepted Answer

Salvage pathway of purine nucleotide synthesis

Answer

Breakdown of purines

Answer

Not involved in purine metabolism

Answer

De novo synthesis of purines

Question 9

Which of the following is not a precursor in the synthesis of pyrimidines?

Accepted Answer

Thymidine

Answer

Glutamine

Answer

Carbon dioxide (CO2)

Answer

Aspartic acid

Question 10

The anticodon region is an important part of which type of RNA?

Accepted Answer

t-RNA

Answer

r-RNA

Answer

m-RNA

Answer

hn-RNA

Nucleic Acid Biochemistry — MCQs

Nucleic Acid Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?